MDA-MB-231 BRE-Luc/TK Renilla cell line

The human breast cancer cell line MDA-MB-31 modified for use as a reporter cell line for bone morphogenetic protein (BMP) signalling. The cell line stably expresses BMP responsive element (BRE)-Luciferase.

Contributors

Inventor Institute
Caroline Hill The Francis Crick Institute
SKU: 156439
Product description: The human breast cancer cell line MDA-MB-31 modified for use as a reporter cell line for bone morphogenetic protein (BMP) signalling. The cell line stably expresses BMP responsive element (BRE)-Luciferase. The cell line also contains a Renilla reporter driven by the thymidine kinase (TK) promoter to act as an internal control. BMP is a transforming growth factor ? (TGF-?) superfamily member.
Conditional description: Luciferase is expressed in the presence of bone morphogenetic protein (BMP) signalling
Production details: Made by transfecting the breast cancer cell line MDA-MB-31 with BRE-Luciferase plasmid, TK Renilla plasmid and pRetroSuper for puromycin resistance. Clonal
Parental cell line: MDA-MB-231 cell line
Disease: Cancer
Cat. #: 156439
Tool sub type: Continuous
Unit size: 1×10^6 cells / vial
Cancer types: Breast cancer
Research Fields: Cancer; Cell signaling and signal transduction; Developmental biology
Organism: Human
Tissue: Breast
Model: Reporter
Cancer Types In Detail: Breast cancer
Format: Frozen
Storage conditions: Liquid Nitrogen
Shipping conditions: Dry ice
Growth medium: Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal calf serum (FCS)+ 50 ?g/ml blasticidin
Recommended controls: MDA-MB-231 parental line
Mycoplasma free: Yes
Biosafety level: 1
References:

Grnroos et al. 2012. Mol Cell Biol. 32(14):2904-16. PMID: 22615489.

Related Tools for Cell lines

Cat. # Tool Name
156440 HEK293T BRE-Luc/TK Renilla cell line Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.